Arax Advisory Partners’s Guardant Health GH Stock Holding History

Arax Advisory Partners’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$128K	Buy	854 +392	+85%	+$42.6K	﹤0.01%	2553
2026 Q1	$43.6K	Sell	462 -271	-37%	-$27.2K	﹤0.01%	1742
2025 Q4	$74.9K	Buy	733 +279	+61%	+$25K	﹤0.01%	1438
2025 Q3	$28.4K	Buy	454 +344	+313%	+$18.7K	﹤0.01%	2111
2025 Q2	$5.72K	Hold	110	–	–	﹤0.01%	2196
2025 Q1	$4.69K	Buy	110 +60	+120%	+$2.59K	﹤0.01%	1804
2024 Q4	$1.53K	Sell	50 -34	-40%	-$956	﹤0.01%	2072
2024 Q3	$1.93K	Hold	84	–	–	﹤0.01%	2077
2024 Q2	$2.43K	Buy	84 +34	+68%	+$792	﹤0.01%	1897
2024 Q1	$1.03K	Sell	50 -50	-50%	-$1.07K	﹤0.01%	1150
2023 Q4	$2.71K	Hold	100	–	–	﹤0.01%	979
2023 Q3	$2.96K	Hold	100	–	–	﹤0.01%	964
2023 Q2	$3.58K	Hold	100	–	–	﹤0.01%	926
2023 Q1	$2.34K	Hold	100	–	–	﹤0.01%	980
2022 Q4	$2.72K	Hold	100	–	–	﹤0.01%	910
2022 Q3	$5K	Hold	100	–	–	﹤0.01%	799
2022 Q2	$4K	Hold	100	–	–	﹤0.01%	824
2022 Q1	$7K	Hold	100	–	–	﹤0.01%	704
2021 Q4	$10K	Hold	100	–	–	﹤0.01%	656
2021 Q3	$13K	Hold	100	–	–	﹤0.01%	605
2021 Q2	$12K	Buy	+100	New	+$13.5K	﹤0.01%	635
2020 Q4	$13K	Hold	100	–	–	﹤0.01%	540
2020 Q3	$11K	Hold	100	–	–	﹤0.01%	530
2020 Q2	$8K	Hold	100	–	–	﹤0.01%	554
2020 Q1	$7K	Buy	+100	New	+$7.67K	﹤0.01%	546

Other funds holding GH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Arax Advisory Partners's GH Position: Q2 2026 in Review

Arax Advisory Partners increased its Guardant Health (GH) stake by 85% in Q2 2026, buying an estimated $42.6K and bringing the position to 854 shares worth $128K. The position accounts for ﹤0.01% of the portfolio, ranked #2553.

Arax Advisory Partners first reported a position in GH in Q1 2020 and has held it in 25 quarters since. 600 funds tracked by Wall St. Rank hold GH as of Q2 2026.

Arax Advisory Partners held 854 shares of Guardant Health worth $128K as of Q2 2026.
Arax Advisory Partners bought 392 Guardant Health shares in Q2 2026, an estimated $42.6K.
Guardant Health made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2553 holding.
Arax Advisory Partners first reported a position in Guardant Health in Q1 2020 and has held it in 25 quarters since.
600 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.